ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Clue and Johns Hopkins University Researchers Unveil Largest Study on Menstrual Cycle, Mood, and Gastrointestinal Symptoms

Berlin, Germany, October 23, 2024 (EZ Newswire) -- Clue, a leading menstrual and reproductive health tracking app, today announced the results of the largest study to date, examining the relationship between gastrointestinal (GI) symptoms, mood, and the menstrual cycle. Led by researchers at Johns Hopkins University, the new study provides important insights into the complex link between GI and mood symptoms across the menstrual cycle, particularly for individuals with premenstrual syndrome (PMS).

The study analyzed data from more than 33,000 menstrual cycles over a four year period, across more than 32,000 participants, making it the most comprehensive study of its kind. Participants used Clue’s menstrual tracking app to identify and track their symptoms and opted-in to share their data anonymously for research.

Key findings:

  • GI symptoms such as bloating, constipation, diarrhea, and nausea were more frequently tracked in the days leading up to menstruation as compared to the days following it, with a stronger effect observed in those with PMS.
  • A strong positive association was found between mood symptoms and GI symptoms across all phases of the menstrual cycle, for both PMS and non-PMS groups, indicating that these symptoms often occur together.
  • Participants with self-reported PMS tracked more GI symptoms throughout their entire menstrual cycle compared to those without PMS.

"At Clue, we're committed to advancing society’s understanding of menstrual health through data-driven research. These findings not only validate the experiences of millions of women and people with cycles, but also pave the way for more effective support and treatment during especially difficult times of their menstrual cycles,” said Amanda Shea, Fractional Chief Science Officer at Clue. 

With the Clue app, members can track when they feel bloated or gassy, monitor constipation or diarrhea, and log mood fluctuations throughout their cycle.  By customizing additional tags, members can capture their unique experiences, and get a clear overview of how gastrointestinal symptoms and mood changes interact during their cycles. 

"Reporting your experiences and discomforts to your healthcare provider from memory alone often doesn't reflect the true condition of your health and might not be the most reliable. We recommend tracking both your digestion and feelings daily, and over a longer period, to help you and your healthcare provider analyze cycle-related patterns,” said Shea.

"This study was exciting because it drew from such a large dataset of menstrual cycles, to give a representative look at GI symptoms and mood across the cycle. We were able to see a clear relationship between GI symptoms and mood at multiple points in the menstrual cycle. Previous studies have found links between GI symptoms and mood in people with major depression, but this had not been assessed in the context of the menstrual cycle or premenstrual mood symptoms. We hope this study leads to more research on the gut-brain axis in the context of menstrual health," said Liisa Hantsoo, Ph.D., Assistant Professor in Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine and Director of Research in the Johns Hopkins Reproductive Mental Health Center.

The full study can be found here

About Clue

Clue is the top women-led menstrual and reproductive health app, loved by over 10 million users around the world. With a science-driven approach, Clue enables members to create a powerful personal health record that uses each cycle as a tool to uncover insight into their overall health. From general cycle health education to fertility, pregnancy, menopausal stages, and all changes and choices in between, the Clue app is CE-marked as a Class 1 medical-grade device. Clue regularly partners with researchers from top institutions and universities to help close the data gap and move female health forward. Based in Berlin, Germany, Clue data is protected by the world's strictest data laws (the EU's GDPR) and by Clue's absolute commitment to standing up for the privacy of its users, no matter where they are. For more, visit helloclue.com.

Media Contact

Kirsten Underwood
213-371-2420
kirsten.underwood.ext@helloclue.com


###

SOURCE: Clue

Copyright 2024 EZ Newswire

See release on EZ Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.